Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Bankruptcy

<< Previous

Bullboard Posts

Next >>

Comment by fasttrack5on Feb 06, 2024 2:26pm

102 Views

Post# 35865830

RE:RE:RE:Bankruptcy

Sunshiney wrote: While it's of little importance, I agree with you. Keep in mind that even dead cats bounce. I'm averaging down and then gettiing out at the inevitable bounce. It was always a part of my "I think I'll take a risk on this" trades and I know that I win some and I lose some. Onward ...

Says you who just signed up today.
aka ????

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China